BusinessElliott Builds Stake in Life-Science Firm Bio-Rad, WSJ Says PMay 18, 2026May 18, 202601 mins Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories to boost the firm’s underperfoming stock price, the Wall Street Journal reported, citing people familiar with the matter. Post navigation Previous: What to Know About the Latest Ebola OutbreakNext: Tiger Woods ‘in good spirits’ after returning home from treatment programme Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Oil rises as Iran-U.S. deadlocked peace talks fan fears of extended supply disruption May 18, 2026May 18, 2026
